Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.

SAN DIEGO, -- Trovagene, Inc. (Nasdaq: TROV), (Nasdaq: TROVU),a developer of trans-renal molecular diagnostics, announced the full exercise of the over-allotment option granted to the underwriters to purchase 172,500 additional units, at a public offering price of $8.00 per unit, in connection with its previously announced underwritten public offering of 1,150,000 units, bringing total gross [...]

NanoLogix Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco

Hubbard, Ohio -- NanoLogix (OTC Markets:NNLX) announced today its R&D team in collaboration with University of Texas Health Science Center - Houston (UTHSC-Houston) researchers, are developing a multi-well, microplate reader variant of the company’s BioNanoFilter (BNF) diagnostics for use in large volume laboratory environments. Early analysis of the multi-well plates shows exceptionally fast live-threat results [...]

Golden Helix Establishes Direct Presence in Japan

Bozeman, MT — Golden Helix has established a representative office in Japan and has selected Filgen, Inc. as its exclusive distributor for the territory. Filgen will work directly with Golden Helix Japan to market and support its flagship product, SNP & Variation Suite (SVS). The software offers several packages to facilitate SNP, copy number, and [...]

Fera and Waters Corp. Announce International Food Safety Training Laboratory

London — The Food and Environment Research Agency (Fera) based in York, U.K., and Waters Corporation (NYSE:WAT) based in the U.S. have today announced that they will open a new laboratory-based training facility, combining their respective regulatory, scientific and industry expertise to help solve the global food safety challenge. According to a recent report from [...]

Simulations Plus Signs Collaboration Agreement

LANCASTER, Calif.-- Simulations Plus, Inc. ( SLP ), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a collaboration agreement with a top-5 pharmaceutical company to extend and enhance its oral cavity dosing model within its industry gold standard GastroPlus™ simulation software program. Walt Woltosz, [...]

SeraCare Launches First Of Its Kind Anti-Dengue Performance Panel

Milford, Mass., – SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, has launched the first commercially available Anti-Dengue Mixed Titer Performance Panel. This new addition to the SeraCare line of infectious disease panels responds to growing demand for [...]

STEMCELL Technologies Inc. to Launch TeSR-E8 – a Novel Medium for Human Embryonic and Induced Pluripotent Stem Cells – and New STEMdiff Kits for Differentiation of these cell types

STEMCELL Technologies Inc. (STEMCELL) announced today its plans to release a series of new products to advance research and translational applications for human pluripotent stem cells. These novel products, which will be launched at the International Society for Stem Cell Research 2012 Conference in Japan, include: TeSR™-E8™: a highly defined feeder-free culture medium for human [...]

Titian Announces Three Installations in China of its Mosaic™ Sample Management Software

LONDON, UK : Leading sample management software provider, Titian Software, has announced three orders in China for its Mosaic™ sample management software, significantly increasing Mosaic’s footprint in the Far East. The orders have come from the research facilities in Shanghai of two major pharmaceutical companies, and at the R&D base in Nanjing of a contract [...]

Bioscale Appoints Proteomics Leader Martin Latterich as Chief Scientific Officer

LEXINGTON, Mass -- BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, today announced the appointment of Martin Latterich, PhD as Chief Scientific Officer (CSO). Dr. Latterich brings nearly 20 years of academic, commercial and technology development experience to BioScale and features an accomplished research career focused on the proteomics-based discovery of [...]

New Products to Advance Research on Human Pluripotent Stem Cells

STEMCELL Technologies Inc. (STEMCELL) announced today its plans to release a series of new products to advance research and translational applications for human pluripotent stem cells. These novel products, which will be launched at the International Society for Stem Cell Research 2012 Conference in Japan, include: TeSR™-E8™: a highly defined feeder-free culture medium for human [...]

Access IBO on Knowledge Center